Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression

Background: The adjuvanted recombinant zoster vaccine (RZV), consisting of varicella-zoster virus glycoprotein E (gE) and the AS01_B adjuvant system, effectively prevents herpes zoster (HZ). In the absence of a well-defined correlate of protection, it is important to monitor the RZV immune...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lorenzo Losa, Ippazio Cosimo Antonazzo, Giuseppe Di Martino, Giampiero Mazzaglia, Silvio Tafuri, Lorenzo Giovanni Mantovani, Pietro Ferrara
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-05-01
Edice:	Vaccines
Témata:	cell-mediated immunity herpes zoster humoral immunity immunogenicity recombinant zoster vaccine vaccine response
On-line přístup:	https://www.mdpi.com/2076-393X/12/5/527
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!